BALTIMORE: Over the past several decades there have been a number of well-financed campaigns, promoted by everyday individuals of the public, to raise awareness to the plight of patients with dementia. Suspiciously, most of these campaigns come from “patient support” groups that have been leading the public to believe that every dementia patient has Alzheimer’s Dementia (AD).
It turns out that many, perhaps all, of these campaigns have been funded in secret by the very pharmaceutical companies that profit by indirectly promoting the sale of so-called Alzheimer’s drugs. Major drug companies have been known to generate public relations campaigns as standard procedure in their operating practices, especially within the psychopharmaceutical drugs sector.
It has been found that the promotion and destigmatization of alleged “mental illnesses” is a great tool for marketing their drugs…